in AlphaGenome Atlas. The AI-powered database exceeds one petabyte and covers both coding and non-coding regions of DNA. Available free to academic researchers, the Atlas is designed to help scientists identify potentially disease-related mutations more quickly. DeepMind is also introducing an AVI score that ranks variants by their predicted impact. The predictions remain a research tool and are nota substitute for experimental validation or clinical diagnosis.
